Baidu
map

Circulation:多国研究提示,五个简单指标可预测艾森曼格综合征患者死亡风险

2016-12-29 朱朱 中国循环杂志

艾森曼格综合征是各种左向右分流的先天性心脏病出现肺动脉高压、形成右向左或双向分流的病理生理综合征,患者死亡风险较高。 近期公布在《Circulation》杂志上的一项大规模国际多中心研究提示,5个简单、无创指标可预测艾森曼格综合征患者的死亡风险,包括年龄、三尖瓣前分流、静息时血氧饱和度、窦性心律、心包填塞。多因素Cox回归分析表明:年龄每增加10岁,死亡风险增加41%;存在三尖瓣前分流者死亡风险增

艾森曼格综合征是各种左向右分流的先天性心脏病出现肺动脉高压、形成右向左或双向分流的病理生理综合征,患者死亡风险较高。

近期公布在《Circulation》杂志上的一项大规模国际多中心研究提示,5个简单、无创指标可预测艾森曼格综合征患者的死亡风险,包括年龄、三尖瓣前分流、静息时血氧饱和度、窦性心律、心包填塞。

多因素Cox回归分析表明:年龄每增加10岁,死亡风险增加41%;存在三尖瓣前分流者死亡风险增加56%;静息时血氧饱和度每升高10%,死亡风险降低47%;维持窦性心律者死亡风险降低47%;存在心包填塞者死亡风险增加141%。

这项研究纳入1098例艾森曼格综合征患者,覆盖了英国、丹麦、中国、美国、挪威、瑞典、比利时、荷兰、波兰、意大利、塞尔维亚等多国的数据。研究显示,近六成(58.6%)的患者存在三尖瓣后缺陷,12.7%存在三尖瓣前病变,28.7%三尖瓣前和瓣后都有病变。中位随访了3.1年,278例患者死亡,6例患者接受心脏移植。

原始出处:


Kempny A, Hjortsh?j CS, Gu H, et al. Predictorsof Death in Contemporary Adult Patients with Eisenmenger Syndrome: AMulticentre Study. Circulation. 2016 Dec 15.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1983497, encodeId=4d34198349e8f, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Jan 30 17:29:00 CST 2017, time=2017-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721603, encodeId=dcab1e2160325, content=<a href='/topic/show?id=1ff586e740e' target=_blank style='color:#2F92EE;'>#艾森曼格综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86774, encryptionId=1ff586e740e, topicName=艾森曼格综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f333043209, createdName=chentianping, createdTime=Thu Apr 20 03:29:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255609, encodeId=588b1255609b1, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Dec 31 02:29:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430741, encodeId=23721430e4100, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 31 02:29:00 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1983497, encodeId=4d34198349e8f, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Jan 30 17:29:00 CST 2017, time=2017-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721603, encodeId=dcab1e2160325, content=<a href='/topic/show?id=1ff586e740e' target=_blank style='color:#2F92EE;'>#艾森曼格综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86774, encryptionId=1ff586e740e, topicName=艾森曼格综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f333043209, createdName=chentianping, createdTime=Thu Apr 20 03:29:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255609, encodeId=588b1255609b1, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Dec 31 02:29:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430741, encodeId=23721430e4100, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 31 02:29:00 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1983497, encodeId=4d34198349e8f, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Jan 30 17:29:00 CST 2017, time=2017-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721603, encodeId=dcab1e2160325, content=<a href='/topic/show?id=1ff586e740e' target=_blank style='color:#2F92EE;'>#艾森曼格综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86774, encryptionId=1ff586e740e, topicName=艾森曼格综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f333043209, createdName=chentianping, createdTime=Thu Apr 20 03:29:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255609, encodeId=588b1255609b1, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Dec 31 02:29:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430741, encodeId=23721430e4100, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 31 02:29:00 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1983497, encodeId=4d34198349e8f, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Jan 30 17:29:00 CST 2017, time=2017-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721603, encodeId=dcab1e2160325, content=<a href='/topic/show?id=1ff586e740e' target=_blank style='color:#2F92EE;'>#艾森曼格综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86774, encryptionId=1ff586e740e, topicName=艾森曼格综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f333043209, createdName=chentianping, createdTime=Thu Apr 20 03:29:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255609, encodeId=588b1255609b1, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Dec 31 02:29:00 CST 2016, time=2016-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430741, encodeId=23721430e4100, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Dec 31 02:29:00 CST 2016, time=2016-12-31, status=1, ipAttribution=)]

相关资讯

包括中国在内的多国研究提示:五个简单指标可预测艾森曼格综合征患者死亡风险

艾森曼格综合征是各种左向右分流的先天性心脏病出现肺动脉高压、形成右向左或双向分流的病理生理综合征,患者死亡风险较高。 近期公布在《Circulation》杂志上的一项大规模国际多中心研究提示,5个简单、无创指标可预测艾森曼格综合征患者的死亡风险,包括年龄、三尖瓣前分流、静息时血氧饱和度、窦性心律、心包填塞。 多因素Cox回归分析表明:年龄每增加10岁,死亡风险增加41%;存在三

Circulation:成人艾森曼格综合征患者死亡的预测因素有哪些?

在当代成年艾森门格综合征患者中存在显著的早发死亡率。在此基础上的多变量死亡风险分层模型中,研究者报告了这类患者的5个简单、无创的死亡预测因子。

Baidu
map
Baidu
map
Baidu
map